You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美单日新增13.43万宗新冠确诊 留院人数降至10万宗以下
阿思达克 02-02 16:04
美国新增新冠确诊数字持续减少。据美国约翰霍普金斯大学统计,美国截至西岸时间午夜(本港时间下午4时),累计确诊26,321,125宗,单日新增134,308宗。累计死亡个案443,355宗,单日新增2,031宗。各州疫情方面,加州累计确诊334.26万宗,德克萨斯州累计确诊241.26万宗,佛罗里达、纽约及伊利诺伊州各累计确诊172.71万、142.88万及112.86万宗,乔治亚州亦累计91.25万宗。

《美国广播公司》报道,美国目前有93,536名新冠病人留院,远低於高峰期的13万人,美国上周有38个州份住院人数减少逾10%,美国至今累计逾80万人因感染新冠入院。统计亦显示,美国上月仍有逾600万宗新增确诊,为疫情爆发以来第二多的月份,累计确诊逾2,600万宗,意味每12名美国人便有1人曾经确诊。

美国过去七日新冠疫情统计:

日期│累计确诊│单日新增确诊│累计死亡│单日新增死亡

2月1日(一)│26,321,125宗│+134,308宗│443,355宗│+2,031宗

1月31日(日)│26,186,817宗│+114,262宗│441,324宗│+1,794宗

1月30日(六)│26,072,555宗│+139,761宗│439,530宗│+2,731宗

1月29日(五)│25,932,794宗│+166,059宗│436,799宗│+3,604宗

1月28日(四)│25,766,735宗│+168,675宗│433,195宗│+4,000宗

1月27日(三)│25,598,060宗│+158,485宗│429,195宗│+3,979宗

1月26日(二)│25,439,575宗│+142,504宗│425,216宗│+4,087宗

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account